High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia

被引：0
|
作者：
Matsuda, Kensuke [1 ]
Yoshida, Takashi [2 ]
Sugimoto, Koichi [1 ]
机构：
[1] JR Tokyo Gen Hosp, Dept Hematol & Oncol, 2-1-3,Yoyogi,Shibuya Ku, Tokyo 1518528, Japan
[2] JR Tokyo Gen Hosp, Dept Pharm, 2-1-3,Yoyogi,Shibuya Ku, Tokyo 1518528, Japan
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 04期
关键词：
D O I：
10.1007/s00277-023-05143-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：971 / 972
页数：2
相关论文
共 50 条
  • [1] High susceptibility of febrile neutropenia in Japanese patients receiving venetoclax plus azacitidine therapy for acute myeloid leukemia
    Kensuke Matsuda
    Takashi Yoshida
    Koichi Sugimoto
    Annals of Hematology, 2023, 102 : 971 - 972
  • [2] Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia
    Kobayashi, Takahiro
    Sato, Honami
    Miura, Masatomo
    Fukushi, Yayoi
    Kuroki, Wataru
    Ito, Fumiko
    Teshima, Kazuaki
    Watanabe, Atsushi
    Fujishima, Naohito
    Kobayashi, Isuzu
    Kameoka, Yoshihiro
    Takahashi, Naoto
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (02) : 285 - 296
  • [3] Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Yamamoto, Kazuhito
    Shinagawa, Atsushi
    DiNardo, Courtney D.
    Pratz, Keith W.
    Ishizawa, Kenichi
    Miyamoto, Toshihiro
    Komatsu, Norio
    Nakashima, Yasuhiro
    Yoshida, Chikashi
    Fukuhara, Noriko
    Usuki, Kensuke
    Yamauchi, Takahiro
    Asada, Noboru
    Asou, Norio
    Choi, Ilseung
    Miyazaki, Yasushi
    Honda, Hideyuki
    Okubo, Sumiko
    Kurokawa, Misaki
    Zhou, Ying
    Zha, Jiuhong
    Potluri, Jalaja
    Matsumura, Itaru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (01) : 29 - 38
  • [4] Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment
    Naka, Ryosuke
    Kondo, Tadakazu
    Nishikubo, Masashi
    Muranushi, Hiroyuki
    Ueda, Yasunori
    Oka, Tomomi
    Wada, Fumiya
    Kanda, Junya
    Yamamoto, Shohei
    Watanabe, Mitsumasa
    Okada, Shinri
    Imada, Kazunori
    Nakabo, Yukiharu
    Mizutani, Yu
    Nannya, Yasuhito
    Ogawa, Seishi
    Ishikawa, Takayuki
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (09) : E251 - E254
  • [5] Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Alary, Anne-Sophie
    Saillard, Colombe
    Hicheri, Yosr
    Mohty, Bilal
    Rey, Jerome
    D'Incan, Evelyne
    Charbonnier, Aude
    Villetard, Ferdinand
    Maisano, Valerio
    Lombardi, Laura
    Ittel, Antoine
    Mozziconacci, Marie-Joelle
    Gelsi-Boyer, Veronique
    Vey, Norbert
    CANCERS, 2022, 14 (08)
  • [6] Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia
    Ramdohr, Florian
    Hennings, Robert
    Monecke, Astrid
    Kayser, Sabine
    HAEMATOLOGICA, 2023, 108 (07) : 1965 - 1967
  • [7] The propriety of upgrading responses to venetoclax plus azacitidine in newly diagnosed patients with acute myeloid leukemia
    Abbott, Diana
    Cherry, Evan
    Amaya, Maria
    McMahon, Christine
    Schwartz, Marc
    Winters, Amanda
    Schowinsky, Jeffrey
    Jordan, Craig T.
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1466 - 1473
  • [8] A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Alvarado, Yesid
    Chien, Kelly
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas
    Daver, Naval
    Issa, Ghayas
    Jain, Nitin
    Bull-Linderman, Debra
    DiNardo, Courtney
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S239 - S240
  • [9] VENETOCLAX PLUS AZACITIDINE AS FIRST LINE THERAPY IN PATIENTS AFFECTED BY ACUTE MYELOID LEUKEMIA: A REAL-LIFE EXPERIENCE
    Lico, A.
    Greco, G.
    Perbellini, O.
    Facchinelli, D.
    Riva, M.
    Miggiano, M. C.
    Pomponi, F.
    Schiavotto, C.
    Scomazzon, E.
    Di Bona, E.
    Ruggeri, M.
    HAEMATOLOGICA, 2021, 106 (10) : 134 - 134
  • [10] Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine
    Zhang, Alexander
    Johnson, Tanner
    Abbott, Diana
    Phupitakphol, Tanit
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    Koullias, Yiannis
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
12345